WO2008142623A3 - Tumor necrosis factor - alpha inhibitors - Google Patents
Tumor necrosis factor - alpha inhibitors Download PDFInfo
- Publication number
- WO2008142623A3 WO2008142623A3 PCT/IB2008/051932 IB2008051932W WO2008142623A3 WO 2008142623 A3 WO2008142623 A3 WO 2008142623A3 IB 2008051932 W IB2008051932 W IB 2008051932W WO 2008142623 A3 WO2008142623 A3 WO 2008142623A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tnf
- necrosis factor
- tumor necrosis
- pharmaceutically acceptable
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
Abstract
The present invention relates to small molecules that inhibit Tumor Necrosis Factor- alpha (TNF-α), for example, by interaction with TNF-α protein or its receptor, thereby lowering the overall TNF-α activity, and that are represented by formula (1) or a stereoisomer thereof, tautomer thereof, or mixture thereof in any ratio; a pharmaceutically acceptable salt, pharmaceutically acceptable solvate, or pharmaceutically acceptable polymorph thereof; wherein: A1, A2, X1, X2, n, R1, R2, R3 and R4 are as defined in the specification. The present invention also relates to processes for the preparation of these small molecules and to pharmaceutical compositions containing them. The present invention further relates to a method of treatment of disorders characterized by increased TNF- α activity, such as inflammation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93054807P | 2007-05-17 | 2007-05-17 | |
US60/930,548 | 2007-05-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008142623A2 WO2008142623A2 (en) | 2008-11-27 |
WO2008142623A3 true WO2008142623A3 (en) | 2009-12-30 |
Family
ID=40032246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2008/051932 WO2008142623A2 (en) | 2007-05-17 | 2008-05-16 | Tumor necrosis factor - alpha inhibitors |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008142623A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2741760A2 (en) | 2011-08-12 | 2014-06-18 | B.S.R.C. "Alexander Fleming" | Tnf superfamily trimerization inhibitors |
JP6275703B2 (en) | 2012-06-08 | 2018-02-07 | ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | FBXO3 inhibitor |
US9849098B2 (en) | 2013-12-09 | 2017-12-26 | University of Pittsburgh—of the Commonwealth System of Higher Education | Compositions and methods for treating respiratory injury or disease |
RU2713886C2 (en) * | 2014-12-10 | 2020-02-10 | Юниверсити Оф Питтсбург - Оф Зе Коммонвэлс Систем Оф Хайе Эдьюкейшн | Compositions and methods of treating diseases and conditions |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999059959A1 (en) * | 1998-05-15 | 1999-11-25 | Astrazeneca Ab | Benzamide derivatives for the treatment of diseases mediated by cytokines |
US20030013708A1 (en) * | 2001-01-16 | 2003-01-16 | Edward Pierson | Therapeutic heterocyclic compounds |
WO2007004958A1 (en) * | 2005-07-04 | 2007-01-11 | Astrazeneca Ab | Pyridopyrimidine derivatives as pde4 inhibitors for the treatment of inflammatory and' immune diseases |
-
2008
- 2008-05-16 WO PCT/IB2008/051932 patent/WO2008142623A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999059959A1 (en) * | 1998-05-15 | 1999-11-25 | Astrazeneca Ab | Benzamide derivatives for the treatment of diseases mediated by cytokines |
US20030013708A1 (en) * | 2001-01-16 | 2003-01-16 | Edward Pierson | Therapeutic heterocyclic compounds |
WO2007004958A1 (en) * | 2005-07-04 | 2007-01-11 | Astrazeneca Ab | Pyridopyrimidine derivatives as pde4 inhibitors for the treatment of inflammatory and' immune diseases |
Non-Patent Citations (4)
Title |
---|
DATABASE PUBCHEM 4 March 2009 (2009-03-04), retrieved from http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pcsubstanceBDbFrom=pcsubstance&Cmd=Link& LinkName=pcsubstance_pcsubstance&LinkReadableName=Similar20Substances8ldsFromRes ult=56442818&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pcsubstance.Pcsubstan Results Panel.Pcsubstan_RVDocSum Database accession no. 25118614. * |
DATABASE PUBCHEM. [online] 4 March 2009 (2009-03-04), retrieved from http://www.ncbi.nim.nih.gov/sites/entrez?Db=pcsubstance&DbFrom=pcsubstance&Cmd=Link &LinkName=pcsubstance_pcsubstance&LinkReadableName=Result=56442816[SID &ordinalpos=1&itool=EntrezSystem2.PEntrez.Pcsubstance.Pcsubstance_ResuItsPaneLPcsubs tance_RVDocSum Database accession no. 25118610. * |
DATABASE PUBCHEM. 4 March 2009 (2009-03-04), retrieved from http://www.nGbi.nlm.nih.gov/sites/entrez?Db=pcsubstance&DbFrom=pcsubstance&Cmd=Link &LinkName=pcsubstance_csubstance&LinkReadableName=Result=44924038[SID]&ordinalp os=1&itool=EntrezSystem2.PEntrez.Pcsubstance.Pcsubstance ResuItsPanel.Pcsubstan_R VDocSum Database accession no. 9825905. * |
HE ET AL.: "Small molecule inhibitors of TNF-alpha.", SCIENCE, vol. 310, November 2005 (2005-11-01), pages 1022 - 1025 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008142623A2 (en) | 2008-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008094992A3 (en) | 2-aminopyridine derivatives useful as kinase inhibitors | |
WO2009155121A3 (en) | Inhibitors of pi3 kinase | |
WO2009106980A3 (en) | Indazole derivatives | |
WO2006086488A3 (en) | Substituted thiophene derivatives as glucagon receptor antagonists, preparation and therapeutic uses | |
WO2008061109A3 (en) | Indazole derivatives useful as melanin concentrating receptor ligands | |
NO20084652L (en) | Deazapurins useful as inhibitors of januskinases | |
HK1131608A1 (en) | Pyridinone compounds | |
WO2007120284A3 (en) | Glucagon receptor antagonists, preparation and therapeutic uses | |
WO2013049726A3 (en) | Processes for making compounds useful as inhibitors of atr kinase | |
WO2010078421A8 (en) | Substituted 5,6-dihydro-6-phenylbenzo[f] isoquinolin-2-amine compounds | |
WO2009155527A3 (en) | Phosphatidylinositol 3 kinase inhibitors | |
WO2010022055A3 (en) | 1, 3, 5 -triaz ine derivatives useful in the treatment of chronic pain disorders | |
WO2005077344A3 (en) | Hydantoin derivatives as inhibitors of cellular necrosis | |
WO2008013987A3 (en) | N-alkyl substituted piperazinylmethylquinazolinones and azepanylmethylquinazolinones | |
EP3363797A8 (en) | Oral dosage form of apoptosis signal-regulating kinase inhibitors | |
WO2008001195A3 (en) | Novel processes for the preparation of dpp iv inhibitors | |
WO2008135826A3 (en) | 2 -pyridine carboxamide derivatives as sodium channel modulators | |
WO2009111700A3 (en) | Oxadiazoanthracene compounds for the treatment of diabetes | |
WO2008057802A3 (en) | Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same | |
WO2005086656A3 (en) | Heteroarylaminopyrazole derivatives useful for the treatment of diabetes | |
WO2008119825A3 (en) | Imidazolidine carboxamide derivatives as p2x7 modulators | |
WO2007095223A3 (en) | Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases | |
WO2009049180A3 (en) | Heteroaryl amides useful as inhibitors of voltage-gated sodium channels | |
WO2007076085A3 (en) | Fused pyrimidones and thiopyrimidones, and uses thereof | |
WO2007087283A3 (en) | Thiophene-carboxamides useful as inhibitors of protein kinases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08751223 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08751223 Country of ref document: EP Kind code of ref document: A2 |